Search for: "Boehringer Ingelheim Pharmaceuticals, Inc."
Results 81 - 100
of 124
Sort by Relevance
|
Sort by Date
22 Nov 2010, 11:14 am
Employment National origin discrimination Where an employee falsified his call records, summary judgment was properly granted to the employer on the claim that he was terminated because of his national origin. [read post]
27 Oct 2010, 9:30 am
Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals Inc. of Ridgefield, Conn., will be available in 75 milligram and 150 milligram capsules. [read post]
14 Jul 2010, 6:47 pm
Sun Pharmaceutical Industries, Inc. [read post]
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
14 Jun 2010, 1:07 pm
That decision was challenged in court, see Boehringer Ingelheim Corp. v. [read post]
31 May 2010, 8:52 pm
Intervet Inc. et al. 1:10-cv-00435; filed May 25, 2010 in the District Court of Delaware • Plaintiff: Wyeth LLC • Defendants: Intervet Inc. d/b/a Intervet/Schering-Plough Animal Health; Boehringer Ingelheim Vetmedica Inc. [read post]
27 May 2010, 3:20 am
Boehringer Ingelheim International GMBH et al. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
13 May 2010, 4:44 pm
The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
5 May 2010, 4:46 am
Cyclacel Pharmaceuticals Inc. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
26 Jan 2010, 9:59 pm
Teva Pharmaceuticals USA, Inc., Proctor & Gamble Co. v. [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
